News and updates
News and Updates Company Updates
OnMarch17,2022,ChinaNationalDrugAdministrationDrugReviewCenter(CDE)approvedfirst
Recently,NanjingBiohengBiotechCo.,Ltd(hereinafterreferredtoas'Bioheng)announ
NanjingBiohengBiotechCo.,Ltd. AnnouncedUCARTcelltherapyproducttargetingCD7,
NANJING,China,March24,2021/PRNewswire/--BiohengBiotechCo.,Ltd,aclinical-stagebio
HANGZHOUandNANJING,China,Nov.10,2020--BiohengBiotechCo.,Ltd,aclinical-stagebiote
An“off-the-shelf”EpsteinBarr-virus–specificcytotoxiclymphocyte(EBV-CTL)CARproduc
Copyright Nanjing Bioheng Biotech Co., Ltd.@ 2018 China All Rights Reserved